Trials / Completed
CompletedNCT01693549
Study of Cabazitaxel in Patients With Metastatic Breast Cancer Previously Treated With Taxanes
Phase II Study of Cabazitaxel as 2nd Line Treatment in Patients With HER-2 Negative Metastatic Breast Cancer Previously Treated With Taxanes
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 84 (actual)
- Sponsor
- Hellenic Cooperative Oncology Group · Academic / Other
- Sex
- Female
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether cabazitaxel is effective in the treatment of metastatic breast cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cabazitaxel |
Timeline
- Start date
- 2012-09-01
- Primary completion
- 2017-07-10
- Completion
- 2017-07-20
- First posted
- 2012-09-26
- Last updated
- 2017-08-01
Locations
17 sites across 1 country: Greece
Source: ClinicalTrials.gov record NCT01693549. Inclusion in this directory is not an endorsement.